Fetal exposure to isotretinoin—An international problem

Isotretinoin is a known teratogen. Pregnancy prevention programs aimed at minimizing isotretinoin exposure in pregnancy have been implemented in North America with limited success. To compare the management of fetal risk of isotretinoin in three countries, including information given to women, imple...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Reproductive toxicology (Elmsford, N.Y.) N.Y.), 2008, Vol.25 (1), p.124-128
Hauptverfasser:	Garcia-Bournissen, Facundo, Tsur, Lilach, Goldstein, Lee H., Staroselsky, Arthur, Avner, Marina, Asrar, Farhan, Berkovitch, Matitiahu, Straface, Gianluca, Koren, Gideon, De Santis, Marco
Format:	Artikel
Sprache:	eng
Schlagworte:	Abnormalities, Drug-Induced - etiology Abnormalities, Drug-Induced - prevention & control Abortion, Therapeutic Adult Biological and medical sciences Canada Contraception Dermatologic Agents - toxicity Drug Information Services Embryology: invertebrates and vertebrates. Teratology Female Fetus - drug effects Follow-Up Studies Fundamental and applied biological sciences. Psychology Global Health Guideline Adherence Health Knowledge, Attitudes, Practice Humans Infant, Newborn Isotretinoin Isotretinoin - toxicity Israel Italy Live Birth Medical sciences Patient Education as Topic Practice Guidelines as Topic Pregnancy Pregnancy Trimester, First Prevention programs Surveys and Questionnaires Teratogen information service Teratogens Teratology. Teratogens Toxicology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!